Variant report
Variant | nsv972000 |
---|---|
Chromosome Location | chr11:33258598-33263953 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000110422 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538126011 | chr11:33258615-33258616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534899453 | chr11:33258702-33258703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183007244 | chr11:33258708-33258709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534423817 | chr11:33258721-33258722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146575238 | chr11:33258816-33258817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371890809 | chr11:33258835-33258836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187712548 | chr11:33258899-33258900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577674875 | chr11:33258901-33258902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35976195 | chr11:33258908-33258909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141298449 | chr11:33258933-33258934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555402086 | chr11:33258948-33258949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74449716 | chr11:33258959-33258960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144691420 | chr11:33258983-33258984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs267427 | chr11:33258991-33258992 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs549536077 | chr11:33259037-33259038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6484652 | chr11:33259100-33259101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182467935 | chr11:33259101-33259102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146852055 | chr11:33259115-33259116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538644996 | chr11:33259200-33259201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187799170 | chr11:33259279-33259280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563873704 | chr11:33259375-33259376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529343332 | chr11:33259377-33259378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549093348 | chr11:33259378-33259379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568894645 | chr11:33259394-33259395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140680330 | chr11:33259433-33259434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551756881 | chr11:33259544-33259545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150479302 | chr11:33259589-33259590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534088684 | chr11:33259599-33259600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554337722 | chr11:33259604-33259605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567908297 | chr11:33259631-33259632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535523739 | chr11:33259639-33259640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555536776 | chr11:33259643-33259644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575279545 | chr11:33259664-33259665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544218065 | chr11:33259672-33259673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557721226 | chr11:33259686-33259687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192617521 | chr11:33259712-33259713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527266676 | chr11:33259719-33259720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138350571 | chr11:33259741-33259742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542397020 | chr11:33259752-33259753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562291198 | chr11:33259778-33259779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567804082 | chr11:33259789-33259790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1969748 | chr11:33259814-33259815 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs1969747 | chr11:33259834-33259835 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs184395423 | chr11:33259857-33259858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs267426 | chr11:33259901-33259902 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs531557601 | chr11:33259902-33259903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs80020185 | chr11:33259909-33259910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565178077 | chr11:33259922-33259923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190007354 | chr11:33259934-33259935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192837867 | chr11:33259953-33259954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 16620391 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:33257600-33258800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr11:33258400-33259000 | Enhancers | Adipose Nuclei | Adipose |
3 | chr11:33258600-33258800 | Enhancers | Brain Substantia Nigra | brain |
4 | chr11:33258800-33259000 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr11:33259000-33263600 | Weak transcription | Adipose Nuclei | Adipose |
6 | chr11:33262800-33263200 | Enhancers | HMEC | breast |
7 | chr11:33262800-33263600 | Enhancers | Hela-S3 | cervix |
8 | chr11:33263000-33263200 | Enhancers | Stomach Mucosa | stomach |
9 | chr11:33263000-33263200 | Enhancers | A549 | lung |
10 | chr11:33263000-33263400 | Enhancers | NHEK | skin |
11 | chr11:33263200-33264600 | Weak transcription | Stomach Mucosa | stomach |
12 | chr11:33263400-33263800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr11:33263600-33264000 | Enhancers | Adipose Nuclei | Adipose |
14 | chr11:33263800-33264400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |